Combining basal insulin with a GLP-1 inhibitor not only may produce favorable reductions in A1c values, but may also lower the risk for hypoglycemia and promote weight loss, reports Dr John Buse.

Paul Ridker and John Cleland agree, and disagree, on the use of aspirin in primary and secondary prevention.

CDC influenza expert Fiona Havers explains when and how antiviral drugs should be used in patients with probable influenza.

Just in time for flu vaccine season, ACIP rolls out new rules for use of pneumococcal vaccines in older adults.

Drs Harrington and Patel review the pros and cons of NOACs and ask why anticoagulation is underused.

In which populations does fish oil slow cognitive decline?

Dr Stephen Krieger discusses new treatments and treatment approaches in multiple sclerosis.

Wilbert Aronow comments on the trial that slammed the door on niacin for lipid-lowering.